Ann Marie Curatolo

Ann Marie Curatolo has a diverse work experience in the field of pharmacovigilance and drug safety spanning over several years. Ann Marie began their career as a Drug Safety/Risk Management/Safety Evaluation Contractor at King Pharmaceuticals in 2009. Ann Marie later worked as a Senior Clinical Safety Scientist at GSK before transitioning to Pfizer, where they served as a Drug Safety/Risk Management/Safety Evaluation Consultant. Afterward, they joined Drug Safety Alliance as a Senior Case Manager, responsible for AE case processing and communication with internal and external stakeholders. Ann Marie then became a Clinical Safety Manager at GTx, Inc., managing pharmacovigilance operations for clinical development products. Their next role was a Senior Clinical Research Manager at Medtronic Spine & Biologics, overseeing the Clinical Device Safety operations. Following this, they served as the Director of Safety at miRagen Therapeutics, Inc., where they were responsible for the development of global safety strategy and management of drug safety services. Prior to their current role as the Sr. Director of PV Operations at Dyne Therapeutics, they held positions as Director of Pharmacovigilance at Rocket Pharmaceuticals and Aeglea BioTherapeutics. Throughout their career, Ann Marie Curatolo has demonstrated expertise in safety surveillance, regulatory compliance, safety signal detection, and management of safety data for regulatory authorities.

Ann Marie Curatolo has a diverse education history. Ann Marie attended the University of Toronto from 1989 to 1996, earning a Bachelor of Science degree with Honors. Their specialist field of study was Neuroscience, with a major in Biology. Following this, from 1996 to 1998, they enrolled at Centennial College, where they pursued a Nursing degree. Finally, in 1999, they participated in a Critical Care Nursing program at the Critical Care Institute CCHS.